185 related articles for article (PubMed ID: 19754574)
1. Investigation of the local expression of the relaxin system in canine mammary tumours.
Lamp O; Honscha KU; Jakob J; Lamp J; Schweizer S; Reischauer A; Gottschalk J; Hahn A; Ebert M; Rothemund S; Blaschzik S; Einspanier A
Reprod Domest Anim; 2009 Jul; 44 Suppl 2():224-9. PubMed ID: 19754574
[TBL] [Abstract][Full Text] [Related]
2. The metastatic potential of canine mammary tumours can be assessed by mRNA expression analysis of connective tissue modulators.
Lamp O; Honscha KU; Schweizer S; Heckmann A; Blaschzik S; Einspanier A
Vet Comp Oncol; 2013 Mar; 11(1):70-85. PubMed ID: 22235833
[TBL] [Abstract][Full Text] [Related]
3. The relationship between tumour size and expression of prognostic markers in benign and malignant canine mammary tumours.
Ferreira E; Bertagnolli AC; Cavalcanti MF; Schmitt FC; Cassali GD
Vet Comp Oncol; 2009 Dec; 7(4):230-5. PubMed ID: 19891693
[TBL] [Abstract][Full Text] [Related]
4. Expression and significance of PTEN in canine mammary gland tumours.
Qiu C; Lin D; Wang J; Wang L
Res Vet Sci; 2008 Oct; 85(2):383-8. PubMed ID: 18082231
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of relaxin action in the reproductive tract: studies in the relaxin-deficient (Rlx-/-) mouse.
Parry LJ; McGuane JT; Gehring HM; Kostic IG; Siebel AL
Ann N Y Acad Sci; 2005 May; 1041():91-103. PubMed ID: 15956691
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of transforming growth factor β (TGFβ) and latent TGFβ binding protein (LTBP)-4 expression in late stage canine mammary tumours.
Klopfleisch R; Schütze M; Gruber AD
Vet J; 2010 Dec; 186(3):379-84. PubMed ID: 19836277
[TBL] [Abstract][Full Text] [Related]
7. Quantification of VEGF-C expression in canine mammary tumours.
Qiu C; Lin DD; Wang HH; Qiao CH; Wang J; Zhang T
Aust Vet J; 2008 Jul; 86(7):279-82. PubMed ID: 18616481
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical evaluation of MMP-2 and TIMP-2 in canine mammary tumours: a survival study.
Santos A; Lopes C; Frias C; Amorim I; Vicente C; Gärtner F; Matos Ad
Vet J; 2011 Dec; 190(3):396-402. PubMed ID: 21269852
[TBL] [Abstract][Full Text] [Related]
9. The hormonal induction of cervical remodeling in the common marmoset monkey (Callithrix jacchus).
Simon C; Einspanier A
Reproduction; 2009 Mar; 137(3):517-25. PubMed ID: 19106202
[TBL] [Abstract][Full Text] [Related]
10. Relaxin expression from tumor-targeting adenoviruses and its intratumoral spread, apoptosis induction, and efficacy.
Kim JH; Lee YS; Kim H; Huang JH; Yoon AR; Yun CO
J Natl Cancer Inst; 2006 Oct; 98(20):1482-93. PubMed ID: 17047197
[TBL] [Abstract][Full Text] [Related]
11. Prolactin binding in benign and malignant mammary tissue of female dogs.
Rutteman GR; Willekes-Koolschijn N; Bevers MM; Van der Gugten AA; Misdorp W
Anticancer Res; 1986; 6(4):829-35. PubMed ID: 3019223
[TBL] [Abstract][Full Text] [Related]
12. Expression of extracellular matrix metalloproteinase (MMP-9), E-cadherin and proliferation-associated antigen Ki-67 and their reciprocal correlation in canine mammary adenocarcinomas.
Nowak M; Madej JA; Podhorska-Okolow M; Dziegiel P
In Vivo; 2008; 22(4):463-9. PubMed ID: 18712173
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical expression of Epidermal Growth Factor Receptor (EGFR) in canine mammary tissues.
Gama A; Gärtner F; Alves A; Schmitt F
Res Vet Sci; 2009 Dec; 87(3):432-7. PubMed ID: 19464036
[TBL] [Abstract][Full Text] [Related]
14. Receptors for oestrogen, progesterone and epidermal growth factor in normal and tumorous canine mammary tissues.
Donnay I; Rauïs J; Wouters-Ballman P; Devleeschouwer N; Leclercq G; Verstegen JP
J Reprod Fertil Suppl; 1993; 47():501-12. PubMed ID: 8229969
[TBL] [Abstract][Full Text] [Related]
15. Comparison of steroid receptor expression in normal, dysplastic, and neoplastic canine and feline mammary tissues.
Millanta F; Calandrella M; Bari G; Niccolini M; Vannozzi I; Poli A
Res Vet Sci; 2005 Dec; 79(3):225-32. PubMed ID: 16054892
[TBL] [Abstract][Full Text] [Related]
16. Increased survival in dogs with malignant mammary tumours overexpressing HER-2 protein and detection of a silent single nucleotide polymorphism in the canine HER-2 gene.
Hsu WL; Huang HM; Liao JW; Wong ML; Chang SC
Vet J; 2009 Apr; 180(1):116-23. PubMed ID: 18061495
[TBL] [Abstract][Full Text] [Related]
17. Derlin-1 and stanniocalcin-1 are differentially regulated in metastasizing canine mammary adenocarcinomas.
Klopfleisch R; Gruber AD
J Comp Pathol; 2009; 141(2-3):113-20. PubMed ID: 19515379
[TBL] [Abstract][Full Text] [Related]
18. Expression of TopBP1 in canine mammary neoplasia in relation to histological type, Ki67, ERalpha and p53.
Morris JS; Nixon C; King OJ; Morgan IM; Philbey AW
Vet J; 2009 Mar; 179(3):422-9. PubMed ID: 18314357
[TBL] [Abstract][Full Text] [Related]
19. Disparate effects of relaxin and TGFbeta1: relaxin increases, but TGFbeta1 inhibits, the relaxin receptor and the production of IGFBP-1 in human endometrial stromal/decidual cells.
Mazella J; Tang M; Tseng L
Hum Reprod; 2004 Jul; 19(7):1513-8. PubMed ID: 15155604
[TBL] [Abstract][Full Text] [Related]
20. Relaxin-a pleiotropic hormone and its emerging role for experimental and clinical therapeutics.
Dschietzig T; Bartsch C; Baumann G; Stangl K
Pharmacol Ther; 2006 Oct; 112(1):38-56. PubMed ID: 16647137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
